Business

Drug Dispute Between Biotech Firms

Updated 2026-05-08 18:50 UTC 2 sources Negative

Capricor Therapeutics has accused Nippon Shinyaku and its U.S. subsidiary of mishandling the rollout of a Duchenne muscular dystrophy treatment, leading to a legal dispute.

Coverage timeline — 2 articles

KFF Health News

The Make America Healthy Again Movement Comes for Hospital Food

Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.

2026-05-08 18:30 UTC

STAT News

STAT+: Capricor Therapeutics accuses Nippon Shinyaku of slow-walking plans on Duchenne drug

Capricor Therapeutics has accused Nippon Shinyaku and its U.S. subsidiary of botching the rollout of a Duchenne muscular dystrophy treatment.

2026-05-08 18:32 UTC